2019
DOI: 10.1371/journal.pone.0209948
|View full text |Cite|
|
Sign up to set email alerts
|

Study on the inflammatory response of PMMA/polystyrene/silica nanocomposite membranes for drug delivery and dental applications

Abstract: BackgroundThe application of polymeric materials in medical industry has grown drastically in the last two decades due to their various advantages compared to existing materials. The present research work emphases on the sol-gel technique to formulate the polymethyl methyl acrylate/polystyrene/silica composite membrane.MethodsThe characteristic of the composite was investigated through modern state art of instrumentation.ResultsThe functional groups attached to the polymer was absorbed by FTIR. The FTIR spectr… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 27 publications
0
8
0
Order By: Relevance
“…PMMA composite shows lower cell viability in the range of 94.6±2 in comparison to AgHAP loaded nanocomposites . It was found that the percentage viability of cells tend to be maximum and fall in the range of 149±3 (for 24 h) and 152±3 (for 48 h) for the nanocomposites having equal ratio of AgHAP:PS:PMMA (SET II, 1:1:1).…”
Section: Resultsmentioning
confidence: 96%
“…PMMA composite shows lower cell viability in the range of 94.6±2 in comparison to AgHAP loaded nanocomposites . It was found that the percentage viability of cells tend to be maximum and fall in the range of 149±3 (for 24 h) and 152±3 (for 48 h) for the nanocomposites having equal ratio of AgHAP:PS:PMMA (SET II, 1:1:1).…”
Section: Resultsmentioning
confidence: 96%
“…Zhang et al [141] onto MCM-41 pore entrants to provide the silica-based nano-container following MSNs synthesis through the surfactant-assisted sol-gel system, with no surfactant removal. The release of the drug could be limited at pH 7.4 in the bloodstream based on the current in vitro results; nevertheless, due to the cancerous cell acidic microenvironment, an accelerated release would be found in cancerous tissues.…”
Section: Dox Sbfmentioning
confidence: 99%
“…Some studies demonstrated addition of different compounds/nanoparticles in membranes for bone regeneration with excellent biological and drug release results. However, it was unclear which sterilization process would be suitable for the new product and/or if the sterilization process could cause some damage to the biomaterials [ [10] , [11] , [12] ]. Moreover, the critical point of BDDS is drug maintenance until reaching the desired moment to apply it in preclinical models or clinical treatments.…”
Section: Introductionmentioning
confidence: 99%